Design of Nanostructures for Versatile Therapeutic Applications Pharmaceutical Nanotechnology Series
Coordonnateur : Grumezescu Alexandru Mihai
Design of Nanostructures for Versatile Therapeutic Applications focuses on antimicrobial, antioxidant and nutraceutical applications of nanostructured materials. Many books discuss these subjects, but not from a pharmaceutical point-of-view. This book covers novel approaches related to the modulation of microbial biofilms, antimicrobial therapy and encapsulate polyphenols as antioxidants. Written by an internationally diverse group of academics, this book is an important reference resource for researchers, both in biomaterials science and the pharmaceutical industry.
Pharmaceutical scientists, biomaterials scientists, toxicologists, biomedical engineers, medicinal chemists and postgraduate students specializing in the areas of nanomedicine, bionanomaterials and nanotechnology applications in healthcare.
- Assesses the most recently developed nanostructures that have potential antimicrobial properties, explaining their novel mechanical aspects
- Shows how nanoantibiotics can be used to more effectively treat disease
- Provides a cogent summary of recent developments in nanoantimicrobial discovery, allowing readers to quickly familiarize themselves with the topic
Date de parution : 01-2018
Ouvrage de 690 p.
19x23.3 cm
Thèmes de Design of Nanostructures for Versatile Therapeutic... :
Mots-clés :
Acitretin; Antibacterial activity; Antimicrobial; Antiparkinsonian agents; Biosensors; Bleeding control bandage; Brain; Cancer; Colonic delivery; Controlled release; Cosmetic; Cosmetics; Cyclodextrin-based nanovehicles for drug delivery; Cyclodextrins; Cyclosporine A; DNA; Dermal drug delivery; Dopaminergic neurons; Drug delivery; Eudragit polymer; Exosomes; Eye; Flavonoids; Gene therapy; Herpes infections; High pressure homogenization; High-valence silver; Inclusion complexes; Inclusion compounds; Induced circular dichroism (ICD); Ionizable lipids; Lipid nanoparticles; Lipid-based colloidal carriers; Lipoplexes; Liposomes; Methotrexate; Micelles; Microbial resistance; Microbiome; Mobilizing and homing drugs; Molecular modeling; Multidrug resistance; Mycobacterium tuberoculosis; Myocardial repair; Myocardium remodeling; NLC; Nanocarriers; Nanogold; Nanomaterials; Nanomedicine; Nanoparticles; Nanosilver; Nanostructured lipid carriers; Nanotechnology; Nanotoxicity; Neurodegeneration; Neurodegenerative diseases; Niosomes; Novel drug delivery system; Ocular drug delivery; Oliconucleotides; Parkinson's disease; Pharmaceutically active dietary polyphenols; Physiological barriers; Polymeric nanoparticles; Polymeric sponges; Polyplexes; Probiotics; Psoriasis vulgaris; QS modulators; Quorum sensing; Quorum sensing (QS); RNA; Reprogramming cells; Respiratory; SLN; SNALPs; Silver chlorhexidine; Silver nanoparticles; Silver pyridoxine; Skin; Solid lipid nanoparticles; Staphylococcus aureus; Steady state and time-resolved fluorescence; Stem cell; Surfactants; Targeted therapy; Targeting; Topical formulations; Ultrasonication; Wound healing; α-synuclein